Skip to Main Content
Prostate, Phase III

Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

What is the purpose of this trial?

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.

  • Trial with
    Memorial Sloan-Kettering Cancer Center
  • Ages
    18 years and older
  • Gender
    Male only

Contact Information

For more information about this study, including how to volunteer, contact Michael Hurwitz

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    09/27/2024
  • Study HIC
    #2000023885